1001 Optometry Deploys AI Pre-Screening Tool to Drive Paediatric Myopia Consultations

The retail optical chain's new Magnif-eye platform uses everyday smartphone photos to flag potential myopia risk in children and funnel families into practice.

Australian optical retail group 1001 Optometry has launched a free AI-powered pre-screening tool called Magnif-eye, designed to identify potential signs of childhood myopia from photos taken on a parent's smartphone. For eyecare professionals, the platform represents an interesting new model for patient acquisition and community engagement. It could reshape how practices have initial conversations with families about children's vision.

The tool works by prompting parents to select multiple existing photos of their child from their camera roll. Magnif-eye's AI then analyses those images for visual behavioural cues associated with short-sightedness such as squinting, head tilting, or proximity to screens while also collecting responses to a short questionnaire covering environmental and lifestyle risk factors. The output is an initial risk indication, along with a recommendation as to whether a comprehensive clinical eye examination is warranted.

The launch comes amid mounting concern over the trajectory of childhood myopia in Australia, with University of Melbourne research suggesting 40 per cent of Australian children could be affected by 2050, a figure that sits within broader global projections of myopia affecting half the world's population by that date.

A Referral Engine Dressed as a Consumer App

From a practice management perspective, Magnif-eye is arguably as much a patient funnel as it is a health tool. The platform sits at the very top of the clinical pathway. It does not diagnose, nor does it replace the optometrist but it is explicitly designed to get more children into the consulting chair sooner.

Retail and Optometry Director Edward Lee framed the concept around a behaviour already deeply embedded in modern parenting: "We know that every parent's phone is a treasure trove of memories, filled with thousands of pictures of their children. That camera roll can be a powerful, preventative health tool."

Lee added that lowering barriers to the first consultation was central to the initiative: "Because a comprehensive eye exam can be bulk-billed through Medicare, it's an accessible next step for every family." That Medicare bulk-billing angle is a practical consideration for practices. It removes a common objection for parents who might otherwise defer an appointment.

Clinical Rationale: Earlier Onset, Faster Progression

Head of Optometry and Professional Services Margaret Lam linked the tool directly to a trend already visible in clinical practice, noting that earlier onset of myopia in children often means faster progression, which in turn significantly increases the risk of more serious conditions such as glaucoma, cataracts, and retinal detachment later in life.

Lam described Magnif-eye as a "vital first step" that gives parents an accessible means to identify potential signs they might otherwise overlook, and said an early conversation with an optometrist can lead to interventions that manage and slow myopia's progression.

This is a message eyecare professionals will recognise. The challenge in paediatric myopia management has long been getting families through the door before a child's vision deteriorates to the point that it affects schooling or daily life. A tool that normalises early screening, without requiring a practice visit as the first touchpoint, could help shift that dynamic.

The approach mirrors a wider trend in healthcare and retail towards self-screening tools designed to identify risk earlier and direct consumers into professional care, with similar models already emerging in areas such as skin checks and hearing assessments.

Privacy by Design

Given that the platform processes photos of children, privacy architecture will be a point of scrutiny for both parents and practitioners recommending it. 1001 Optometry says photos submitted through Magnif-eye are deleted immediately after analysis, processed on secure Australian servers, and are not stored, shared, or viewed by any person. The company describes customer images as transient data streams rather than retained files.

For practices considering how to position the tool in patient communications, those privacy credentials are likely to be a necessary reassurance.